As usual, you junk science preaching antivaxxer, you buried the lead.
Learning points
This case should alert healthcare providers to the possibility of fatal complications of vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination estimated to occur in up to 29% of patients with VITT.
The high mortality rate associated with VITT may decrease with earlier recognition and improved intervention.
The risk of VITT remains far lower than severe COVID-19, therefore, the benefit of vaccination still exceeds the risks.